Advertisement

Expression of the Heterotrimeric G Protein Gi and ATP Release are Impaired in Erythrocytes of Humans with Diabetes Mellitus

  • Randy Sprague
  • Alan Stephenson
  • Elizabeth Bowles
  • Madelyn Stumpf
  • Gregory Ricketts
  • Andrew Lonigro
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 588)

Abstract

Erythrocytes of humans have been reported to stimulate nitric oxide (NO) synthesis in the circulation as a consequence of their ability to release ATP in response to both mechanical deformation and exposure to reduced oxygen tension. It has been proposed that the ability of the erythrocyte to affect local vascular resistance permits it to participate in the regulation of blood flow such that oxygen delivery is matched with metabolic need. A signal transduction pathway that relates deformation and exposure to reduced oxygen tension to ATP release from human erythrocytes has been described. The heterotrimeric G protein, Gi, is a critical component of this pathway. Importantly, stimulation of Gi results in activation of adenylyl cyclase and ATP release from these cells. Recently, in a model of diabetes mellitus in rats, expression of Gi was reported to be decreased in the aorta. We report that expression of Gαi2 is selectively decreased in erythrocytes of humans with type 2 diabetes (DM2) and that these erythrocytes fail to release ATP in response to incubation with mastoparan 7(10 µM), an agent that activates Gi. These results provide support for the hypothesis that ATP release from erythrocytes of humans with DM2 is impaired and this defect in erythrocyte physiology could contribute to the vascular disease associated with this clinical condition.

Key Words

mastoparan 7 heterotrimeric G proteins western analysis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bagi, Z., Koller, A. and Kaley, G.: Superoxide-NO interaction decreases flow-and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus. Am. J. Physiol 285: H1404–H1410, 2003.Google Scholar
  2. 2.
    Bayewitch, M.L., Avidor-Reiss, T., Levy, R., Pfeuffer, T. et al.: Differential modulation of adenylyl cyclase I and II by various GΒ subunits. J. Biol. Chem. 273:2273–2276, 1998.PubMedCrossRefGoogle Scholar
  3. 3.
    Bergfeld, G.R. and T. Forrester. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnea. Cardiovasc. Res. 26:40–47, 1992.PubMedGoogle Scholar
  4. 4.
    Brownlee, M., Cerami, A. and Vlassara, H.: Advanced glycosylation end producs in tissues and the biochemical basis of diabetic complications. N.E.J.M. 318, 1315–1321, 1988.CrossRefGoogle Scholar
  5. 5.
    Communi, D., Raspe, E., Pirotton, S. and Boeynaems, J.M.: Coexpression of P2y and P2u receptors on aortic endothelial cells: Comparison of cell localization and signaling pathways. Circ. Res. 76:191–198, 1991.Google Scholar
  6. 6.
    Costagliola, C: Oxidative state of glutathione in red blood cells and plasma of diabetic patients: In vivo and in vitro study. Clin. Physiol. Biochem. 8:204–210, 1990.PubMedGoogle Scholar
  7. 7.
    Dazel, H.H. and Westfall, D.P.: Receptors for adenine nucleotides and nucleosides: Subclassification, distribution and molecular characterization. Pharmacological Reviews 46:449–466, 1994.Google Scholar
  8. 8.
    Ellsworth, M.L.: Red blood cell derived atp as a regulator of skeletal muscle perfusion: Med. Sci. Sports Exerc, Vol. 36, No. 1, pp. 3541, 2004.Google Scholar
  9. 9.
    Ellsworth, M.L.: The red blood cell as an oxygen sensor: what is the evidence? Acta. Physiol. Scand. 168:551–559, 2000.PubMedCrossRefGoogle Scholar
  10. 10.
    Federman, A.D., Conklin, B.R., Schrader, K.A., Reed, R.R. and Bourne, H.R.: Hormonal stimulation of adenylyl cyclase therough Gi-protein beta gamma subunits. Nature 356:159–161, 1992.PubMedCrossRefGoogle Scholar
  11. 11.
    Gonzalez-Alonzo, J., Olsen, D.B., Saltin, B.: Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery. Circ. Res. 91:1046–1055, 2002.CrossRefGoogle Scholar
  12. 12.
    Hashim, S., Liu, Y.Y., Wand, R. and Anand-Srivastava, M.B.: Streptozotocin-induced diabetes impairs G-protein linked signal transduction in vascular smooth muscle. Molecular and Cellular Biochemistry 240:57–63, 2000CrossRefGoogle Scholar
  13. 13.
    Hayashi, Y., Leishits, L., Caduff, A. and Feldman, Y.: Dielectric spectroscopy study of specific glucose influence on humans erythrocyte membranes. J Physics D: Applied Physics 36:369–374, 2003.CrossRefGoogle Scholar
  14. 14.
    Hsueh, W.A. and Quinones, M.J.: Role of endothelial dysfunction in insulin resistance. Am. J. Cardiol. 92(suppl):10j–17j, 2003.PubMedCrossRefGoogle Scholar
  15. 15.
    Katsu, T., Kuroko, M., Morikawa, K., Sanchika, K., Yamanaka, H., Shinoda, S. and Fujita, Y: Interaction of wasp venom mastoparan with biomembranes. Biochemica et Biophysica Acta 1027:185–190, 1990.CrossRefGoogle Scholar
  16. 16.
    Kennedy, C, Delbro, D. and Burnstock, G.: P2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery. Eur. J. Pharmacol. 1072:161–168, 1985.CrossRefGoogle Scholar
  17. 17.
    McLellan, A.C., Thornalley, P.J., Benn, J. and Sonksen, P.H.: Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. 87:2-29, 1994.Google Scholar
  18. 18.
    McMillan, D.E., Utterback, N.G. and La Puma, J.: Reduce erythrocyte deformability in diabetes. Diabetes 27:895–901, 1978.PubMedGoogle Scholar
  19. 19.
    Hayes, J.R.: Impared endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:771–776, 1992.PubMedGoogle Scholar
  20. 20.
    Mokdad, A.H., et al.: Diabetes trends in the U.S.:1990–1998, Diabetes Care, 23: 1278–1283, 2000.PubMedCrossRefGoogle Scholar
  21. 21.
    Olearczyk, JJ, Ellsworth, ML, Stephenson, AH, Lonigro, AJ and Sprague, RS: Nitric oxide inhibits ATP release from rrythrocytes. J Pharmacol. Exp. Ther. 309: 1079–1084, 2004.PubMedCrossRefGoogle Scholar
  22. 22.
    Olearczyk, JJ, Stephenson, AH, Lonigro, AJ and Sprague, RS: Receptor-mediated Activation of the Heterotrimeric G-protein Gs results in ATP Release from Erythrocytes. Med. Sci. Monit. 7:669–674, 2001.PubMedGoogle Scholar
  23. 23.
    Olearczyk, JJ, Stephenson, AH, Lonigro, AJ and Sprague, RS: Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes Am. J. Physiol 286:H940–H945, 2004.CrossRefGoogle Scholar
  24. 24.
    Petruzzi, E., Orlando, C, Pinzani, P., et al.: ATP release by osmotic shock and HbA1c in diabetic subject’s erythrocytes. Metabolism 43:435–440, 1994.PubMedCrossRefGoogle Scholar
  25. 25.
    Rabini, R.A., Petruzzi, E., Staffolani, R., Tesei, M., Fumelli, P., Pazzagli, M. and Mazzanti, L.: Diabetes mellitus and subjects’s ageing: a study on the ATP content and ATP-related enzyme activities in humans erythrocytes. Eur. J. Clin. Invest. 27:327–332, 1997.PubMedCrossRefGoogle Scholar
  26. 26.
    Sowers, J.R. and Haffner, S.: Treatment of cardiovascular and renal rick factors in the diabetic hypertensive. Hypertension 40:781–788, 2002.PubMedCrossRefGoogle Scholar
  27. 27.
    Sprague, R.S., Ellsworth, M.L., Stephenson, A.H., Kleinhenz, M.E. and A.J. Lonigro. Deformation-induced ATP release from red blood cells requires cystic fibrosis transmembrane conductance regulator activity. Am. J. Physiol. 275:H1726–H1732, 1998.PubMedGoogle Scholar
  28. 28.
    Sprague, RS, Bowles, EA, Olearczyk, JJ, Stephenson, AH and Lonigro, AJ: The role of G protein Β subunits in the release of ATP from human erythrocytes. J. Physiol & Pharmacol 53:667–674, 2002.Google Scholar
  29. 29.
    Sprague, R.S., M.L. Ellsworth, A.H. Stephenson, and A.J. Lonigro. ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am. J. Physiol. 271:H2717–H2722, 1996.PubMedGoogle Scholar
  30. 30.
    Sprague, RS, Ellsworth, ML, Stephenson AH and Lonigro, AJ: Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation of ATP release Am. J. Physiol. 281:C1158–C1164, 2001.Google Scholar
  31. 31.
    Tang, W. and Gilman, A.G.: Type-specific regulation of adenylyl cyclase by G protein Βγ subunits. Science 254:1500–1503, 1991.PubMedCrossRefGoogle Scholar
  32. 32.
    The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complicationof inulin-dependent diabetes mellitus. N.E.J.M. 329:977–986, 1993.CrossRefGoogle Scholar
  33. 33.
    van Kampen, E.J. and W.G. Zijlstra. Spectrophotometry of hemoglobin and hemoglobin derivatives. Adv. Clin. Chem. 23:199–257, 1983.PubMedCrossRefGoogle Scholar
  34. 34.
    van Etten, R.W., de Koning, E.J.P., Verhaar, M.C., Gaillard, C.A.J.M. and Rabelink, T.J.: Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 45:1004–1010, 2002.PubMedCrossRefGoogle Scholar
  35. 35.
    Yugar-Toledo, J.C. et al.: Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. Chest 125:823–830, 2004PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Randy Sprague
    • 1
  • Alan Stephenson
    • 1
  • Elizabeth Bowles
    • 1
  • Madelyn Stumpf
    • 1
  • Gregory Ricketts
    • 1
  • Andrew Lonigro
    • 1
  1. 1.Department of Pharmacological and Physiological ScienceSaint Louis University, School of MedicineSt. LouisUSA

Personalised recommendations